Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05300763 · ClinicalTrials.gov registry record · NA

Clinical Performance of Senofilcon A Investigational Lens

A NA study of Visual Acuity, sponsored by Johnson & Johnson Vision Care.

Completed
Registry status
NA
Development phase
344
Enrollment target
19
Study locations

NCT05300763 is a NA study of Visual Acuity that has completed, run by Johnson & Johnson Vision Care. The registered enrollment target is 344 participants, above the 123-participant average among 20 other Visual Acuity trials with a reported enrollment target (180% higher). The trial reports 19 study locations across 11 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05300763, a NA study of Visual Acuity, has completed, sponsored by Johnson & Johnson Vision Care.

COMPLETED
Registry status
NA
Development phase
344 participants
Enrollment target
19
Study locations

Study Summary

This study is a controlled, randomized, subject-masked, 2-arm parallel, 2-week dispensing, bilateral evaluation where the study lenses are worn for a minimum of 5 days per week and 6 hours per day.

Conditions Studied

Interventions

  • DEVICE senofilcon A prototype
  • DEVICE Dailies Total 1

Study Locations (19)

Florida

  • Vue Optical Boutique - Jacksonville
  • Dr. James Weber & Associates, PA - City Square Blvd - Jacksonville
  • Stam & Associates Eye Care - Jacksonville
  • Sabal Eye Care - Longwood
  • Maitland Vision Center - North Orlando Ave - Maitland
  • Flora Chen Poveda, OD, PA - Orange Park - Orange Park
  • Southwest Orlando Eye Care - Orlando
  • Tallahassee Eye Center - Tallahassee

Tennessee

  • Optometry Group, LLC - Memphis
  • Total Eye Care - Memphis

California

  • Randall Go, OD - San Francisco

Georgia

  • VisualEyes - Roswell

Kansas

  • Kannarr Eye Care - Pittsburg

Michigan

  • Birmingham Vision Care - Bloomfield

New York

  • Sacco Eye Group - Vestal

Ohio

  • ProCare Vision Centers - Granville

Trial Details

FieldValue
Enrollment Target 344 participants
Start Date 2022-03-21
Est. Completion 2022-05-25
Phase NA

Sponsor

Johnson & Johnson Vision Care

142 total trials

What the Registry Record Tells You About NCT05300763

The ClinicalTrials.gov registry entry for NCT05300763 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 344 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 123-participant average among 20 other Visual Acuity trials with a reported enrollment target (180% higher). The listed sponsor is Johnson & Johnson Vision Care, which has 142 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Visual Acuity appearing as the primary indexed condition, and to 2 interventions - of which senofilcon A prototype is the first listed.

NCT05300763 reports 19 study locations spanning 11 distinct geographic areas - top geographies include Florida, Tennessee, California.

Frequently Asked Questions

What is clinical trial NCT05300763 about?

NCT05300763 is a clinical study titled "Clinical Performance of Senofilcon A Investigational Lens". This study is a controlled, randomized, subject-masked, 2-arm parallel, 2-week dispensing, bilateral evaluation where the study lenses are worn for a minimum of 5 days per week and 6 hours per day.

What is the current status of trial NCT05300763?

This trial is currently completed. It is a NA study. The enrollment target is 344 participants. The study started on 2022-03-21. Estimated completion is 2022-05-25.

What conditions does trial NCT05300763 study?

This clinical trial studies the following conditions: Visual Acuity.

What interventions are being tested in trial NCT05300763?

The interventions under investigation include: senofilcon A prototype (DEVICE), Dailies Total 1 (DEVICE).

Who is sponsoring clinical trial NCT05300763?

This trial is sponsored by Johnson & Johnson Vision Care, which has 142 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05300763 being conducted?

This trial has 19 study locations across California, Florida, Georgia, Kansas, Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Visual Acuity

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.